A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Sube BanerjeeNicolas FarinaCatherine HendersonJuliet HighSusan StirlingLee ShepstoneJulia FountainClive G BallardPeter BenthamAlistair BurnsChristopher FoxPaul T FrancisRobert HowardMartin KnappIracema LeroiGill LivingstonRamin NilforooshanShirley NurockJohn Tiernan O'BrienAnnabel C PriceAlan J ThomasAnn Marie SwartTanya TellingNaji TabetPublished in: Health technology assessment (Winchester, England) (2023)
; Vol. 27, No. 23. See the NIHR Journals Library website for further project information.